Nafarelin
Also known as: Synarel
Clinical Status
FDA Approved — endometriosis, central precocious puberty.
Mechanism of Action
A potent GnRH agonist administered intranasally. Causes initial gonadotropin stimulation followed by desensitization, resulting in suppression of ovarian and testicular steroid production.
Dosing Defaults
Dose
200-400 mcg twice daily
Frequency
2x daily
Administration
Intranasal spray
Timing
Morning and evening
Food
with or without
Duration
6 months for endometriosis
Dose range: 200-800 mcg daily (intranasal)
Twice daily intranasal dosing maintains consistent hormone suppression.
Side Effects
- •Hot flashes
- •Nasal irritation
- •Headache
- •Mood changes
- •Vaginal dryness
- •Bone density loss
Contraindications & Warnings
- ⚠Pregnancy
- ⚠Undiagnosed vaginal bleeding
- •Not medical advice
- •Avoid nasal decongestants within 30 minutes
Compare
Compare Nafarelin with another peptide side-by-side.
Ad
Related Hormonal Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.